There are many studies that examine the psychosocial adjustment of survivors of bone marrow transplantation (BMT). On the other hand, there are relatively few studies that examine the psychosocial adjustment of patients prior to BMT, and even fewer that focus on the psychosocial adjustment of the patient's caregiver. The purpose of the present study was to assess performance status and psychosocial adjustment to illness, mood and stress response of patients and caregivers prior to admission for allogeneic BMT. Forty patients and their 39 caregivers were assessed using standardized measures. One-fourth of the patients reported clinical levels of psychosocial maladjustment on the Psychosocial Adjustment to Illness Scale and had greater adjustment problems than BMT survivors. Approximately onethird (35%) and one-quarter (23%) of the patients reported significant symptoms of intrusive and avoidance stress responses, respectively on the Impact of Events Scale. Caregivers reported more impairments in family relationships than patients, but overall reported similar distress to that of patients. Information about the pre-BMT process appears to be critical to understanding the psychosocial impact that BMT can have on patients and their caregivers. Bone Marrow Transplantation (2001) 27, 1181-1188.
experience of patients anticipating BMT. Of the studies that do describe the pre-transplant period, findings indicate that the time period before transplantation is an important stage in the BMT process. Patients are confronted with the potential traumatic impact of BMT, a fear of dying, and concerns about the demanding medical treatment, 4 in addition to concerns about changes in their domestic, social and work environments. Not surprisingly, this time period has been described as stressful. 4 In one of the largest studies to examine psychosocial adjustment in BMT candidates, approximately one-third of patients reported symptoms of depression. 4 Their scores on the Profile of Mood States also suggested that they were experiencing high levels of psychological distress. In another study of psychosocial adjustment to BMT, approximately two-thirds of patients reported high levels of anxiety. 5 The significance of pre-transplant psychological distress to length of survival post BMT has also been examined. Colon et al 6 reviewed routine psychiatric evaluations of 100 patients undergoing allogeneic BMT to determine if mood was associated with length of survival post BMT. They found that depressed mood prior to transplantation was associated with lower survival rates after transplantation.
The pre-transplant period is important for family members of BMT candidates as well. However, the effect of the BMT on family members has received little attention. While there are no specific data on caregivers (ie family member, spouse, significant other) of allogeneic BMT patients, available data from caregivers of autologous or allogeneic patients suggest that caregivers experience psychosocial problems. Using a measure to assess general mental and emotional state, Keogh et al 5 found that caregivers reported considerable psychological distress before and during the short-term recovery of transplantation. Zabora et al 7 examined family psychosocial issues in relation to the BMT recipient through structured interviews. When asked how family members perceived the patient's chances of survival, preliminary results suggest that family members perceive their patient's mortality as lower than that of other patients. While such a response is understandable, this misperception can contribute to future distress if the patient does not survive. 7 Data that examine the impact of cancer simultaneously on the patient and caregiver have found mixed results. Sev-eral studies have shown that patients and their caregivers do not differ in their level of psychological distress. For example, using the Psychosocial Adjustment to Illness Scale, Baider and Kaplan De-Nour [8] [9] found similar levels of psychological distress in breast, colon, and testicular cancer patients and their spousal caregivers. Despite these findings, other studies suggest that patients and their caregivers differ in their level of psychological distress. Cassileth et al 10 compared scores on the Profile of Mood States between cancer patients and their family caregivers and found that patients reported greater mood disturbance than caregivers. Keitel et al, 11 however, suggested that family members reported greater psychological distress than cancer patients prior to cancer surgery. Thus, it is unclear what might account for these reported differences in psychological distress and it seems that more information is needed to better understand these differences.
Other studies have also found that gender differences are important to understanding adjustment to illness. These studies tend to suggest that females may be at greater risk than males for experiencing emotional distress related to illness or the caregiving experience. For example, female candidates of BMT, 4 female patients and caregivers of colon cancer 12 and a mixed female cancer population reported more emotional distress and/or caregiver burden than their male counterparts. 13 In a study examining gender relationship in melanoma patients and their spouses, Baider et al 14 found that female patients reported more distress. Their scores on the Impact of Events Scale also suggested that the disease was more intrusive to them than to male patients. Similarly, spouses' scores on the Impact of Events Scale suggested that wives had more intrusive reactions to the patient's disease than did husbands.
Taken together, these findings emphasize the importance of studying the caregiver, in addition to the patient. Caregiver distress can result from many things and may vary at different points in the BMT process. For example, a patient's diagnosis (acute myelogenous leukemia vs chronic myelogenous leukemia), disease status (new disease vs recurrent disease), relationship to the patient (spouse vs a friend), or gender of the patient or caregiver can all contribute to caregiver distress. This paper was not intended to examine all of these medical and/or demographic variables. It was designed to look at the degree of distress experienced by the patient and his/her caregiver. Both the patient and his/her caregiver experience emotional, physical and/or social distress in relation to the experience of cancer, the course of illness, medical treatment, etc. In turn, the patient's recovery is probably influenced by the support and care provided by the family. The caregiver's ability to cope and adjust probably affects not only his/her quality of life but also his/her ability to support and facilitate the patient's recovery. The ability to adjust to the potentially traumatic BMT including the preparative medical tests and procedures, hospitalization, and changes in work and social roles before it is implemented, may be important in predicting who will adapt to the lengthy recovery periods and who will not.
The present study was undertaken to explore psychosocial and psychological differences in BMT patients and their primary caregivers. In order to begin to address these issues we asked the following questions: (1) what is the psychosocial adjustment to illness, mood, and stress response of patients and their caregivers prior to allogeneic BMT? and (2) are patients' responses similar to or different from those of their primary caregiver?
Patients and methods

Sample
Study participants were 40 individuals who would be receiving an allogeneic BMT and their 39 primary caregivers. Caregivers, identified by the patients, were those who had a sustained relationship with the patients and had primary responsibility for provision of emotional support and physical care. Eligibility criteria included ability to read and write English, 18 years of age or older, consent to undergo BMT, and a diagnosis of chronic myelogenous leukemia, acute myelogenous leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, acute lymphoblastic leukemia, or aplastic anemia. Patients undergoing a second BMT were excluded. A total of 33 eligible patients were identified at the University of Chicago Medical Center and seven at Indiana University Hospital between January 1996 and March 1998. Although all patient caregivers also consented to participation, one caregiver failed to complete the questionnaires. The study was approved by the Institutional Review Board at each participating institution.
Procedures and measures
Eligible patients were identified in collaboration with the bone marrow transplant physicians and nurse coordinators at participating institutions. An introductory letter explaining the purpose and procedure of the study was sent or given to the patient. The project coordinator or nurse coordinator then contacted the patient by telephone or in the outpatient clinic to explain study procedures further, respond to questions, and obtain informed consent. The patient was then asked for the name of his/her primary caregiver, and introductory letters were mailed or given to the caregiver. At the University of Chicago, all patient questionnaires were completed at the time of a clinic visit, at least 2 weeks before the BMT. Caregivers, if not accompanying the patient, were contacted by telephone to obtain verbal consent and to administer the interviewer completed measure (ie Karnofsky); the project coordinator, trained in the administration of the Karnofsky, made the ratings. Questionnaires and a written consent form were then mailed; caregivers either completed forms on their own (returned via mail) or if requested by the caregiver, completed questionnaires via telephone interview. Consent forms were returned in pre-addressed stamped envelopes provided. At Indiana University, under separate cover, the project coordinator mailed questionnaires to the patient and questionnaires and a consent form to the caregiver. Telephone interview appointments were scheduled and caregivers were asked to return the signed consent form in the preaddressed stamped envelope provided. The project coordi-nator conducted the telephone interview with patients and caregivers separately. The project coordinator asked questions and recorded responses while the participant simultaneously followed the questions with his/her copy of the questionnaires. The use of centralized telephone interviewing as a psychosocial assessment method has been established as practical, feasible, and valid in populations of cancer patients. 15 Additionally, multiple survey methodology studies have confirmed the equivalence of telephone interviews to in-person interviews.
16,17
Measures
Measurement design was based on findings in the literature deemed important to assess. All measures were included based on documented reliability and validity, easy completion, and usefulness with cancer and non-cancer populations.
Demographic, disease and treatment data (DDT):
The DDT was used to collect basic demographic data (eg age, race, marital status, education, income, and employment status) and record disease and treatment data (eg diagnosis, date of diagnosis, and chemotherapy regimen) which were abstracted from the patient's medical chart.
Karnofsky performance status rating scale:
The Karnofsky is a brief clinician rated scale used to assess global functioning in areas of self-care and work ability. There are no standardized guidelines for the use of this scale; therefore, interviewers were trained based on procedures recommended by Schag et al. 18 First, participants were asked about their activities, daily living (self-care, ambulatory needs, working), energy/fatigue level, and about symptoms of their disease or other illness. Secondly, the project coordinator rated the scale based on their responses to these questions; ratings are in deciles from 0 to 100, with higher scores indicate better functioning. 19 
Psychosocial Adjustment to Illness Scale -Self Report (PAIS-SR):
The PAIS-SR is a 46 item questionnaire, with each item rated on a 4-point scale. A normative profile, based on t scores, is available for a mixed cancer patient cohort. 20 The PAIS-SR provides information about psychological and social adaptation of medical patients across seven domains: health care orientation, vocational environment, domestic environment, sexual relations, extended family, social environment, and psychological distress. Scores are combined to yield a total score as well as summary scores for each dimension. Higher scores are indicative of poorer adjustment.
Following procedures employed by Baider and Kaplan De-Nour 8 and with permission for use of this version by Clinical Psychometric Research, the PAIS-SR was revised for administration to a non-patient population, that is, the patient's caregiver. Specifically, questions were rephrased 'how much of the patient's illness interfered with your work and duties around the house' 'has the patient's illness resulted in a decrease in communication between you and your family' to ask caregivers about the impact of the patient's illness on him/her (caregiver). While the PAIS has Bone Marrow Transplantation not been formally validated for use with caregivers, this format has been used in many studies 9, 12, 21 in order to compare caregiver, spouse, or family adjustment to that of the patient.
Profile of Mood States -Short Form (POMS-SF):
This measure is a shortened version of the 65 item POMS. It consists of 30 adjectives each rated on a 5-point Likert scale. Data are summarized as scores on six mood states: tension, depression, anger, vigor, fatigue, and confusion. Scores are combined to yield a total mood disturbance score with higher scores indicating greater mood disturbance. 22 
Impact of Events Scale (IES):
The (IES) is a 15 item scale with each item, or event, rated from 0 (not at all) to 5 (often). The IES measures two strategies of subjective stress response (intrusive vs avoidance) associated with a specific stressful event. Participants are asked to rate 'how frequently is each item true for you, for the event and its context, about which you are dealing in treatment.' The specific stressful event was defined as the upcoming BMT. That is, participants were asked to think about events leading up to the BMT including preparative medical procedures and tests, hospitalization, changes in work and social roles, fear of dying, etc. We intentionally did not limit the stressful event to a single event. Given that stress is a subjective experience, it is likely that different people will experience different aspects of the upcoming BMT at various stress levels. Thus, we assumed that participants would think about an event or combination of events that was most stressful to them. A separate score for each subscale was calculated, with higher scores indicating more stress. 23 As documented in the literature with medical populations, a score of у20 on either subscale is indicative of significant stress response.
24,25
Statistical analyses
The primary goal of the study was to provide descriptive data on the psychosocial adjustment of patients and their caregivers prior to admission for allogeneic BMT. Thus, analyses are primarily descriptive in nature and outcome data are presented in terms of means, standard deviations, and frequencies. To aid in interpretation of outcome data and provide a reference to compare scores, BMT patients' responses on the PAIS-SR and POMS-SF were compared with the same items from other BMT groups (similar to pre-BMT patients in demographic and medical characteristics) using independent sample t-tests. Paired t-tests were then used to examine patient and caregiver differences. Because it was unreasonable to assume that scores of associated patients and caregivers were independent, 26 we chose to use paired t-tests to examine patient-caregiver differences on psychosocial adjustment, mood, and stress response. Total scores, as well as subscale scores were included in all analyses. The PAIS-SR total score was obtained by summing the seven domains: health care orientation, vocational environment, domestic environment, sexual relations, extended family, social environment and psychological distress, with higher scores indicating poorer adjustment. The total mood disturbance (TMD) for the POMS-SF was obtained by summing the six mood states: tension, depression, anger, vigor (weighted negatively), fatigue and confusion, with higher scores indicating greater mood disturbance. A separate score for each subscale (intrusion and avoidance) of the IES was obtained with higher scores indicating greater stress response. Additionally, preliminary exploratory analyses were used to examine gender differences between patients and caregivers. Because no hypothesis was made on the direction of the difference between patient and caregiver, statistical significance was based on two-tailed tests, P Ͻ 0.05.
Results
Patient characteristics
Patients were 26 men and 14 women with an average age of 40 years (range, 19-58 years). Over two-thirds were white (77%), married (70%), and had incomes greater than $30 000 (73%) and approximately one-third were college educated (35%). Patients had leukemia diagnoses as follows: acute myeloid (45%), chronic myelogenous (18%), acute lymphoblastic (21%) and chronic lymphocytic (3%). Others were diagnosed with non-Hodgkin's lymphoma (5%) or myelodysplastic syndrome (8%). Fifteen patients were newly diagnosed and 25 had recurrent disease. All patients with recurrent disease had undergone primary treatment including chemotherapy, radiation, and/or surgery. The average time between completion of study questionnaires and BMT was 14 days. Global performance status, as rated on the Karnofsky scale, was fair, with one-third of patients scoring 70 or below, indicating some impairment in daily activities or work (see Table 1 ).
Patients with newly diagnosed disease and those who had recurrent disease did not differ statistically on any of the outcome measures.
Caregiver characteristics
Caregivers were 14 men and 25 women with an average age of 44 years (range, 21-79 years). The majority of caregivers were spouses (72%); others were a parent (13%), sibling (10%), child (3%), or friend (3%). Over two-thirds were white (77%), married (87%), and had incomes greater than $30 000 (75%). Fifty-four percent were employed fulltime and 28% were college educated. Not surprisingly, global performance status, as rated on the Karnofsky scale, was excellent with almost all (92%) scoring 80 or above (able to perform normal activities with minimal impairment). Three individuals scored 70 or below due to some significant medical disability or impairment (see Table 1 ).
Patient's emotional status
Psychosocial adjustment: Thirty-eight of the 40 patients completed the PAIS-SR; two patients failed to complete the questionnaire. Compared to the normative profile of a mixed cancer patient population on active medical treatment, 20 pre-BMT patients reported similar levels of adjust- ment to illness. Mean t scores were within one standard deviation of the mixed cancer patients' mean on all subscale and total scores. Approximately 25% of the BMT patients had total psychosocial adjustment scores that were greater than a t score of 62, indicating clinical levels of psychosocial maladjustment. 20 To aid in interpretation mean scores of pre-BMT patients were compared to a mixed group (allogeneic and autologous) of long-term BMT survivors. 27 The long-term survivors were similar to the pre-BMT patients in demographic and medical characteristics. As presented in Table 2 , significant differences were detected on the total adjustment score and on all subscales with the exception of the sexual and family relations subscale. Pre-BMT patients displayed significantly greater total adjustment problems and higher degrees of impairment in vocational, domestic and social adjustment and psychological distress than the BMT survivors (P Ͻ 0.05). Pre-BMT patients, however, reported significantly fewer problems in health care orientation than BMT survivors, indicating better attitudes toward their treatment and doctors (P Ͻ 0.05). Table 2 presents mean scores on the POMS-SF for the pre-BMT patients compared to a group of allogeneic BMT survivors. 28 The BMT survivors were similar to the pre-BMT patients in demographic and medical character- 29 Although the identified stressful event differed for both groups (ie BMT vs cancer diagnosis) the instrument does permit comparisons for different kinds of stressful events. 30 Additionally, 35% of study patients scored above the cutoff of 20 on the intrusion scale and 23% scored above the cutoff on the avoidance scale, indicating moderate to severe stress response symptoms.
Mood:
Patient-caregiver differences
Psychosocial adjustment: Of the 40 patients and 39 caregivers, there were 37 completed patient-caregiver groups on the PAIS-SR (Table 3 ). Significant differences were detected between patients and caregivers on several subscales. Caregivers reported more disturbance in extended family relationships (P Ͻ 0.01) and health care orientation (P = 0.01) (eg poor expectancies about patients' illness and treatment). Patients, however, reported greater impairments in their vocational environments (P = 0.01) indicating difficulty performing their Bone Marrow Transplantation Table 3 Reported differences between pre-BMT patient (PT) and caregiver (CG) groups on PAIS-SR and POMS-SF work, increased absenteeism, or changes in work goals due to illness. No significant differences were found for social and domestic environment, sexual relationship, and psychological distress.
Mood: Thirty-eight patient-caregiver groups were compared on the POMS-SF (Table 3) . No significant differences between patients and caregivers were found on the total mood disturbance or subscale indices (anger, tension, vigor, depression, fatigue) of the POMS-SF. Although it appeared that caregivers reported more anger than patients, the difference did not reach statistical significance (P = 0.06).
Stress response: Thirty-nine patient-caregiver groups were compared on the IES. Based on IES mean scores, patients and caregivers did not differ in the degree to which they responded to BMT stress with avoidance, that is, denial of the situation, emotional numbness and counterphobic activity. On the other hand, although not statistically significant, caregivers reported more intrusive reactions (mean = 17.97, s.d. = 8.4) than patients (mean = 14.76, s.d. = 8.2, P = 0.08). For example, caregivers reported an increased frequency of troubled dreams, thinking about the BMT process when they did not mean to, experiencing strong feelings about it, and being easily reminded about the BMT process.
Gender differences
The differences between male and female patients' subscale and total scores on the PAIS-SR and POMS were small and non-significant. Only on the IES intrusion subscale, did female patients (mean = 17.9, s.d = 6.8) report significantly higher scores than male patients (mean = 12.7, s.d. = 8.5, P Ͻ 0.05). No significant differences were found for the IES avoidance subscale. Similarly, the differences between male and female caregivers were small and non-significant with the exception of the vigor subscale of the POMS-SF. On the vigor subscale, male caregivers (mean = 10.5, s.d. = 4.3) reported significantly higher scores than female caregivers (mean = 6.3, s.d. = 3.2, P Ͻ 0.01), indicating that males reported more energy/less fatigue than female caregivers.
Discussion
This study examined psychosocial adjustment to illness, mood and stress response of patients prior to admission for allogeneic BMT and compared these reactions to other patient groups as well as to those of their caregivers. Further exploratory analyses were conducted to examine gender differences among patient and caregiver groups. Although data are preliminary, results are intriguing and underscore the need to examine further the potential impact of a BMT on the lives of patients and family members.
Results indicate that there is significant emotional distress among patients prior to admission into hospital for an allogeneic BMT. Patient scores on the PAIS-SR, a measure used to assess psychosocial adjustment to illness, were similar to those reported by cancer patients undergoing active medical treatment (ie chemotherapy); a time known to be considerably stressful. 10 Furthermore, 25% of patients had clinical levels of psychosocial maladjustment and, compared to BMT survivors, reported more problems in this area.
Few studies to date have addressed the pre-transplantation period. Data that are available are inconsistent. Rodrigue et al 2 found that BMT candidates do not experience emotional distress. These findings are not consistent with the current data and those reported by other researchers, [4] [5] [6] who found that pre-BMT patients report psychological distress. The apparent contradiction in these findings may be due to different assessment measures utilized or perhaps that premorbid psychological distress not assessed in any of these studies influenced questionnaire responses. Individual differences to stress can also be used to explain the difference. According to crisis theory, a situational crisis such as an illness affects family members of the ill patient in different ways. Some may adapt positively by finding a way to cope with the problem, while others may not adapt and therefore regress to a negative emotional state. 31 Therefore, it seems that more information is needed before any conclusions can be drawn about the pre-transplantation period.
Examination of differences in psychosocial adjustment (as measured by the PAIS-SR) and mood (as measured by the POMS-SF) between pre-BMT patients and BMT survivors revealed more problems in the pre-BMT group. On the PAIS-SR, pre-BMT patients reported significantly more impairments than BMT survivors 27 in five of the eight domains -overall psychosocial adjustment, vocational, domestic and social adjustment, and psychological distress. Although standard norms are not available for comparisons with cancer patients on the POMS-SF, pre-BMT patients reported significantly greater levels of tension than BMT survivors. 28 These findings indicate that the demands of the pre-transplant period may be greater and require more adjustment for patients than during the post-transplant period. However, the differences observed between pre-BMT patients and BMT survivors may be limited due to methodological differences in comparison studies (eg differences in comparison samples utilized (mixed group of allogeneic and autologous 27 vs only allogeneic 28 ) or data collection. In terms of stress response symptoms as assessed by the IES, approximately one-third of pre-BMT patients had significant symptoms of intrusive stress response and onequarter had symptoms of avoidance stress response, respectively. Studies that have used the IES, have suggested that the presence of these symptoms are indicators of later psychological distress. 32 Psychological distress pre-BMT has been associated with shorter survival time post BMT, 6, 33 while better quality of life has been associated with longer survival. 33 However, we were not able to determine with our sample whether distress prior to BMT was a result of the upcoming BMT, a pre-existing condition, or confusion related to the complex medical information received about BMT. 34 Regardless, data support the fact that patients are experiencing psychological distress prior to admission into the hospital for BMT. Health care providers need to be aware of the potential emotionally distressful period prior to BMT and that patients may benefit from additional supportive services. If distress was reduced, patients might experience improvements in quality of life that might potentially impact post-BMT survival.
The period prior to an allogeneic BMT appears to be a time of considerable distress for all of those closely involved in the process, with caregivers reporting similar or more problems than patients on all measures. Although few statistically significant differences were found on the PAIS-SR, caregivers experienced greater impairments in extended family relationships. In general it has been reported that problems in extended family relationships can influence caregiver distress. 35 This finding may be attributable to an added sense of responsibility, changes in role, and general distress. For example, caregivers must often take on new responsibilities, and their previous work, domestic, and other functional roles become subordinate to their caregiving duties. 36 The caregiver's ability to cope and adjust probably affects family and other interpersonal relationships as well.
Another factor that may impact caregiver distress is satisfaction with health care. Caregivers reported more problems in health care orientation than patients indicating that they had poor expectancies about the patient's illness, were unhappy with the patient's treatment, and felt uninformed about the patient's illness. Perhaps caregivers reported more dissatisfaction than patients in health care orientation because they are less involved in decision making or have a less personal relationship with the medical staff.
The similarity in responses of patients and caregivers on measures of adjustment, mood and stress response in the current population is consistent with other research assessing patients and family members. 10 Thus, the time prior to admission into hospital for BMT appears to be an equally significant emotional experience for both patients and their caregivers. Therefore, caregivers should not be regarded solely as a patient's support system, but rather as individuals who may themselves be in need of additional family, social or other supportive services.
With respect to demographic data, gender was of little significance when examining within patient and caregiver group differences. Female patients reported more intrusive reactions to the BMT on the IES than male patients, indicating that they had troubled dreams about the BMT, thought about it when they did not mean to, experienced strong feelings about it, and were easily reminded about the BMT process. According to sociocultural norms, gender differences exist with regards to the sick role. 21 For example, women may be less likely to express feelings of anxiety about illness in order to avoid overburdening her caregiver (eg spouse). Subsequently, these feelings are internalized and perhaps portrayed as intrusive stress responses. However, these findings should be interpreted with caution given the small number of patients and caregivers by gender and the lack of a more formal analysis.
Limitations of the study include a relatively modest sample size and the lack of a simultaneously assessed comparison group of other patients. The sample size may have restricted the power to detect differences between patients and caregivers. Also, the interpretation of the data is limited by the restricted focus to patients and caregivers of allogeneic BMT only. This study would benefit from a comparison study of other cancer or non-cancer groups (eg renal transplantation) in order to determine if the findings are specifically related to allogeneic BMT, or if they are general effects encountered by patients and caregivers who are anticipating an intensive period of medical treatment.
Despite these limitations, this is one of the first studies to assess BMT patients and their primary caregivers prior to admission into hospital for transplantation. Our data point to two areas for future consideration. First, it is important to recognize that cancer patients as well as caregivers have emotional responses to BMT from the earliest phase of the transplant procedure. Continued assessment of adjustment variables (eg adjustment to illness, emotional adjustment), in addition to qualitative assessment (eg structured interview) may help to identify those at risk for future adjustment problems post-BMT, and therefore facilitate prevention and treatment. 37 Second, it is important for health care providers to recognize that caregivers are individuals with their own psychosocial needs when making recommendations rather than solely part of a marital, family, or social dyad. Appreciation for this fact is critical as many caregivers will have an active role in allogeneic BMTs and an even greater role in outpatient BMTs in the future. Ongoing work will continue to shed light on these issues and provide data from which to develop informed interventions.
